Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Oric Pharmaceuticals (ORIC) Shares Issued (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Shares Issued readings, the most recent being $60.9 million for Q1 2026.

  • Quarterly Shares Issued changed N/A to $60.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $62.9 million through Mar 2026, changed N/A year-over-year, with the annual reading at $2.0 million for FY2025, 98.42% down from the prior year.
  • Shares Issued hit $60.9 million in Q1 2026 for Oric Pharmaceuticals, up from $944000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $133.9 million in Q2 2025 and bottomed at -$132.9 million in Q3 2025.
  • Average Shares Issued over 5 years is $15.2 million, with a median of $535000.0 recorded in 2024.
  • The largest annual shift saw Shares Issued surged 139244.26% in 2023 before it plummeted 105568.25% in 2025.
  • Oric Pharmaceuticals' Shares Issued stood at $25.0 million in 2022, then tumbled by 439.76% to -$84.9 million in 2023, then soared by 246.43% to $124.4 million in 2024, then tumbled by 99.24% to $944000.0 in 2025, then surged by 6349.26% to $60.9 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Shares Issued are $60.9 million (Q1 2026), $944000.0 (Q4 2025), and -$132.9 million (Q3 2025).